Perspective - Journal of Dermatology Research and Skin Care (2025) Volume 9, Issue 2
Cosmetic Resurfacing for Melasma: Effective Treatments and Results
Sohrab Faezi *
Department of Health Research, Baqiyatallah University of Medical Sciences, Iran
- *Corresponding Author:
- Sohrab Faezi
Department of Health Research, Baqiyatallah University of Medical Sciences, Iran
E-mail: f.sohrab@yahoo.com
Received: 03-Apr -2025, Manuscript No. AADRSC-25-163876; Editor assigned: 04-Apr-2025, PreQC No. AADRSC-25-163876 (PQ); Reviewed:18-Apr-2025, QC No. AADRSC-25-163876; Revised:23-Apr-2025, Manuscript No. AADRSC-25-163876 (R); Published:28-Apr-2025, DOI:10.35841/aara-9.2.261
Citation: Faezi S. Cosmetic resurfacing for melasma: Effective treatments and results. Dermatol Res Skin Care. 2025; 9(2):261
Introduction
Melasma is a common hyperpigmentation disorder that affects millions worldwide, particularly individuals with darker skin tones and those exposed to excessive sunlight. Characterized by brown or grayish patches on the face, melasma is often resistant to treatment [1].
Cosmetic resurfacing techniques have emerged as effective solutions for managing and reducing melasma, offering promising results for individuals seeking a clearer complexion. This article explores various resurfacing treatments, their effectiveness, risks, and scientific evidence supporting their use [2].
Understanding Melasma Melasma is caused by excessive melanin production due to factors such as hormonal changes, UV exposure, and genetic predisposition. It primarily affects the cheeks, forehead, upper lip, and chin, making it a challenging condition to treat. While topical treatments like hydroquinone and retinoids are commonly prescribed, many patients turn to cosmetic resurfacing techniques for long-term improvement [3].
Chemical peels, such as glycolic acid, salicylic acid, and trichloroacetic acid (TCA) peels, help exfoliate the skin and reduce pigmentation. Studies show that repeated sessions of chemical peels significantly improve melasma symptoms [4].
This technique involves the mechanical exfoliation of the outer skin layer, enhancing cell turnover and promoting even skin tone [5].
Fractional laser, Q-switched Nd:YAG laser, and picosecond laser are widely used for melasma treatment. Research indicates that laser treatments, particularly when combined with topical therapy, provide effective and lasting results [6].
Microneedling enhances the penetration of topical agents like tranexamic acid, improving pigmentation reduction. Studies confirm that this combination yields better outcomes than microneedling alone [7].
IPL therapy targets melanin and vascular components of melasma, effectively lightening hyperpigmented patches. Many dermatologists recommend combining resurfacing techniques, such as laser therapy and chemical peels, for optimal results. A combination of TCA peels and microneedling has shown significant success in clinical trials [8].
While cosmetic resurfacing treatments offer promising results, certain risks should be considered: Individuals with darker skin tones are at higher risk of developing PIH after aggressive resurfacing treatments. Chemical peels and laser treatments can cause temporary redness, peeling, and irritation [9].
Post-treatment sun protection is crucial to prevent melasma recurrence and worsening pigmentation. Found that glycolic acid peels improved melasma in 70% of patients after six sessions. Demonstrated that microneedling with tranexamic acid led to a 60% reduction in melasma severity. Reported that fractional laser combined with hydroquinone provided superior long-term results compared to laser alone [10].
Conclusion
Cosmetic resurfacing treatments offer effective solutions for melasma management, providing significant improvement in skin tone and texture. While chemical peels, microneedling, laser therapy, and IPL show promising results, a personalized approach tailored to the patient’s skin type and severity of melasma is crucial. Future research and advancements in aesthetic dermatology will continue to refine these techniques, ensuring safer and more effective treatment options.
References
- Chen SC, Pennie ML, Kolm P, et al. Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists.J Gen Intern Med. 2006;21:678-82.
- Morrison A, O’Loughlin S, Powell FC. Suspected skin malignancy: a comparison of diagnoses of family practitioners and dermatologists in 493 patients. Int J Dermatol. 2001;40:104-7.
- Tran H, Chen K, Lim AC, et al. Assessing diagnostic skill in dermatology: a comparison between general practitioners and dermatologists.Australas J Dermatol. 2005;46:230-4.
- Basra M, Fenech R, Gatt R, et al. The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results.Br J Dermatol. 2008;159(5):997-1035.
- Woodruff PW, Higgins EM, Du Vivier AW, et al. Psychiatric illness in patients referred to a dermatology-psychiatry clinic. Gen Hosp Psychiatry. 1997;19(1):29-35.
- Bowe WP, Leyden JJ, Crerand CE, et al. Body dysmorphic disorder symptoms among patients with acne vulgaris. J Am Acad Dermatol. 2007;57(2):222-30.
- Kittler JE, Menard W, Phillips KA. Weight concerns in individuals with body dysmorphic disorder. Eat Behav. 2007;8(1):115-20.
- Paprottka FJ, Rolfes SB, Richter DF, et al. COVID?19 pandemic: evaluation of socio?economic impact on aesthetic plastic surgery providers. Aesthetic Plast Surg. 2021;8:1?
- Phillips KA, Menard W, Fay C, et al. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. 2005;46(4):317-25.
- Picavet V, Gabriëls L, Jorissen M, et al. Screening tools for body dysmorphic disorder in a cosmetic surgery setting. The Laryngoscope. 2011;121(12):2535-41.
Indexed at, Google Scholar, Cross ref
Indexed at, Google Scholar, Cross ref
Indexed at, Google Scholar, Cross ref
Indexed at, Google Scholar, Cross ref
Indexed at, Google Scholar, Cross ref